SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of ANSYS to Synopsys
January 16, 2024 09:28 ET
|
Johnson Fistel, LLP
SAN DIEGO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of ANSYS, Inc. (NASDAQ: ANSS) (“ANSYS” or...
Response to Novel Immune Therapy for Ulcerative Colitis Associated with Genetic and Immune Biomarkers
October 03, 2017 12:16 ET
|
Qu Biologics
VANCOUVER, British Columbia , Oct. 03, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...